e-learning
resources
Vienna 2009
Tuesday, 15.09.2009
Persistent asthma: still an uncontrolled disease requiring new treatments strategies in 2009
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Airway inflammatory mediators and airway wall remodelling in asthma
K. Górska, R. Krenke, J. Kosciuch, P. Korczynski, M. Zukowska, J. Domagala-Kulawik, R. Chazan (Warsaw, Poland)
Source:
Annual Congress 2009 - Persistent asthma: still an uncontrolled disease requiring new treatments strategies in 2009
Session:
Persistent asthma: still an uncontrolled disease requiring new treatments strategies in 2009
Session type:
Oral Presentation
Number:
3048
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
K. Górska, R. Krenke, J. Kosciuch, P. Korczynski, M. Zukowska, J. Domagala-Kulawik, R. Chazan (Warsaw, Poland). Airway inflammatory mediators and airway wall remodelling in asthma. Eur Respir J 2009; 34: Suppl. 53, 3048
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Management of Severe Asthma in Pediatric Patients by an Interdisciplinary Team in a Public Hospital Setting.
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Related content which might interest you:
Allergen-induced airway remodelling
Source: Eur Respir J 2007; 29: 1020-1032
Year: 2007
Airway remodelling in asthma is related to particular characteristics of airway inflammation
Source: Eur Respir J 2002; 20: Suppl. 38, 188s
Year: 2002
Role of cytokines and chemokines in bronchial hyperresponsiveness and airway inflammation and remodelling
Source: Annual Congress 2007 - PG1 - Asthma: from bench to bedside
Year: 2007
Airway remodeling in asthma
Source: Research Seminar 2012 - Pulmonary inflammation in paediatric respiratory disease
Year: 2012
Inflammatory cells and airway remodelling in COPD
Source: International Congress 2019 – It takes two to tango: translating scientific findings into clinical applications
Year: 2019
Bronchial wall inflammatory cells and signs of remodeling in COPD and asthma
Source: International Congress 2019 – Immunopathological mechanisms of lung disease
Year: 2019
Novel concepts in airway inflammation and remodelling in asthma
Source: Eur Respir J 2015; 46: 1796-1804
Year: 2015
Continuous airway inflammation is related to the development of airway remodeling
Source: Annual Congress 2012 - Mechanisms and modulation of allergic inflammation in the lung
Year: 2012
Increased arginase activity contributes to airway remodelling in chronic allergic asthma
Source: Eur Respir J 2011; 38: 318-328
Year: 2011
Exercise and airway physiology: interactions with immune and allergic responses
Source: ISSN=ISSN 1025-448x, ISBN=ISBN 1-904097-22-7, page=10
Year: 2005
Airway inflammation and airway pathophysiology in older asthmatics
Source: Annual Congress 2011 - New mechanisms in airway disease
Year: 2011
Effect of bronchial neutrophilia on airway remodeling in asthma
Source: International Congress 2019 – Cellular responses and cell therapy in lung injury and repair
Year: 2019
Increased airway closure is a determinant of airway hyperresponsiveness
Source: Eur Respir J 2008; 32: 1563-1569
Year: 2008
Autoimmunity in airway inflammation and asthma
Source: International Congress 2017 – GR3 Scientific Grand Round: Autoimmunity in chronic lung disease
Year: 2017
Osteopontin exacerbates airway hyperresponsiveness and lung remodeling in chronic asthma
Source: Annual Congress 2008 - Basic science in asthma and COPD
Year: 2008
Treating asthma means treating airway smooth muscle cells
Source: Eur Respir J 2008; 32: 265-274
Year: 2008
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept